Beasley Allen in the News

Articles 461 to 470 of 634.

Senate investigators interview lawyer who has sued Merck

THE NEW YORK TIMES | November 2, 2004

Senate investigators examining Merck's recall of its Vioxx painkiller have interviewed an Alabama lawyer whose firm has filed 58 lawsuits against the company on

Merck Falls on Report of Secrecy

THE RECORD | November 2, 2004

Shares of Merck & Co. plunged again Monday after a news report suggested the drug maker attempted to keep safety worries from hurting the prospects of Vioxx before the company finally recalled the painkiller.

Merck's Woes Grow As Credit Rating is Put on Watch

THE WALL STREET JOURNAL | November 2, 2004

Amid growing concern about litigation over Vioxx, the painkiller yanked off the market, Merck & Co. shares fell nearly 10% and Standard & Poor's Rating Services placed the company's triple-A corporate credit and senior unsecured debt rating on watch with negative implications.

Merck Stock Tumbles nearly 10 Percent

November 2, 2004

Merck & Co.'s shares fell nearly 10 percent, to the lowest price in almost nine years, after The Wall Street Journal reported that the drug maker tried for years to stop safety concerns from hurting sales of its blockbuster arthritis drug Vioxx.

Lawyers put pressure on Merck over Vioxx

November 2, 2004

Plaintiffs' attorneys stepped up pressure on Merck on cases related to its withdrawal of Vioxx, the anti-inflammatory drug, sending the US drugmaker's shares plummeting again.

Merck Falls on report of Secrecy

November 2, 2004

Shares of Merck & Co. plunged again after a news report suggested the drug maker attempted to keep safety worries from hurting the prospects of Vioxx before the company finally recalled the painkiller.

How bad will the lawsuits get, Really, Really Bad.

November 1, 2004

Surveying the wreckage of the worst pharmaceutical tort litigations of the past, investors naturally want to know: Will Vioxx be the next Baycol, or Rezulin, or fen-phen? Our prediction is: yes, but bigger.

Lawyers look to Vioxx recall to Boost Plaintiffs Cases

October 25, 2004

Plaintiffs' attorneys are predicting that Merck & Co.'s recall of Vioxx will significantly enhance their odds of convincing jurors that the popular arthritis medication caused their clients' heart attacks and strokes.

Response to Merck's Press Conference regarding Vioxx

October 13, 2004

Merck's press conference was very disappointing, according to Andy Birchfield, "Instead of accepting responsibility for putting a dangerous drug on the market and keeping it there for so long, Merck spent an hour defending itself."

Lawsuits looming as Vioxx Recalled

October 13, 2004

Lawsuits. Lawsuits. Lawsuits. And they're coming fast. The recall came after testing revealed the risk of heart attack or stroke doubled for those taking Vioxx.